Gene · 3073
Papers1,522
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,522
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a Polygenic Risk Score for BMI to Assess the Genetic Susceptibility to Obesity and Related Diseases in the Korean Population. | Int J Mol Sci | 2023 | 37511320 | PubTator, text mining | PubMed |
| A Genome-Wide Screen for the Exonisation of Reference SINE-VNTR-Alus and Their Expression in CNS Tissues of Individuals with Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37511314 | PubTator, text mining | PubMed |
| Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix. | Genome Biol | 2023 | 37480112 | PubTator, text mining | PubMed |
| A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface. | Front Immunol | 2023 | 37475853 | PubTator, text mining | PubMed |
| Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease. | Mol Neurodegener | 2023 | 37468915 | PubTator, text mining | PubMed |
| A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses. | Front Oncol | 2023 | 37456238 | PubTator, text mining | PubMed |
| Recent advances in RNA-targeting therapy for neurological diseases. | Neural Regen Res | 2023 | 37449612 | PubTator, text mining | PubMed |
| Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). | Bioimpacts | 2023 | 37431483 | PubTator, text mining | PubMed |
| An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity. | Nat Chem Biol | 2023 | 37400536 | PubTator, text mining | PubMed |
| Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation. | Nat Commun | 2023 | 37400440 | PubTator, text mining | PubMed |
| Adaptation of the binding domain of Lactobacillus acidophilus S-layer protein as a molecular tag for affinity chromatography development. | Front Microbiol | 2023 | 37383629 | PubTator, text mining | PubMed |
| Lysosomal storage disorders: from biology to the clinic with reference to India. | Lancet Reg Health Southeast Asia | 2023 | 37383036 | PubTator, text mining | PubMed |
| Clinical and genetic features of a case with juvenile onset sandhoff disease. | BMC Neurol | 2023 | 37344817 | PubTator, text mining | PubMed |
| A case of Sandhoff disease caused by a novel β-hexosaminidase B (HEXB) mutation c.118delG (p.A40fs*24): A case report from China. | Medicine (Baltimore) | 2023 | 37327298 | PubTator, text mining | PubMed |
| Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis. | Int J Mol Sci | 2023 | 37298170 | PubTator, text mining | PubMed |
| Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches. | Front Cell Infect Microbiol | 2023 | 37293206 | PubTator, text mining | PubMed |
| Autophagosome membrane expansion is mediated by the N-terminus and cis-membrane association of human ATG8s. | Elife | 2023 | 37288820 | PubTator, text mining | PubMed |
| COVID-19 impedimetric biosensor based on polypyrrole nanotubes, nickel hydroxide and VHH antibody fragment: specific, sensitive, and rapid viral detection in saliva samples. | Mater Today Chem | 2023 | 37284350 | PubTator, text mining | PubMed |
| Multimodal optical imaging and genetic features of AB variant GM2 gangliosidosis: a case report. | Front Pediatr | 2023 | 37215589 | PubTator, text mining | PubMed |
| A simple urine test by 3D-plus-3D immunoassay guides precise in vitro cancer diagnosis. | Bioeng Transl Med | 2023 | 37206218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3073/papers?page=7